MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Pain"

  • 2017 International Congress

    Central pain processing in “drug-naïve” pain-free patients with Parkinson’s disease

    R. De Micco, A. Russo, F. Esposito, A. Giordano, M. Fratello, G. Caiazzo, M. Cirillo, G. Tedeschi, A. Tessitore (Naples, Italy)

    Objective: To investigate whether central pain processing is altered in “drug-naive” pain-free Parkinson disease (dnPD) patients. Background: Despite its clinical relevance, the pathophysiology of pain…
  • 2017 International Congress

    Occupational Therapy for patients with Parkinson’s disease in the context of Bangladesh

    R. Hoque (Dhaka, Bangladesh)

    Objective: To determine impact of Occupational Therapy for patients with Parkinson’s disease in the context of Bangladesh. Background: Patients with Parkinson’s disease are always at risk…
  • 2017 International Congress

    Safinamide improves both motor and non-motor symptoms in fluctuating Parkinson’s Disease patients.

    C. Cattaneo (Bresso (Milan), Italy)

    Objective: To investigate the efficacy of safinamide, compared to placebo, as add-on therapy to stable doses of levodopa, on both motor and non-motor symptoms in…
  • 2017 International Congress

    Interrelation between chronic pain syndrome and cognitive and affective disturbances in patients with Parkinson’s disease

    K. Stepanchenko (Kharkiv, Ukraine)

    Objective: To study interrelation of chronic pain syndrome and cognitive and affective disorders in patients with PD Background: Parkinson's disease (PD) is characterized by well-known…
  • 2017 International Congress

    Assessment of pain in Parkinson’s disease: comparison between clinical and self-reported measures

    C. Rodriguez-Blazquez, R. Balestrino, K. Chaudhuri, J.M. Rojo-Abuin, A. Rizos, C. Trenkwalder, A. Sauerbier, P. Odin, A. Antonini, P. Martinez-Martin (Madrid, Spain)

    Objective: To compare the performance of several pain measures, self- and rater-based, in PD patients. Background: Pain is a prevalent and complex symptom in Parkinson’s…
  • 2017 International Congress

    Riding the puzzle: deep brain stimulation and the non-motor symptoms in Parkinson’s disease

    A.C. Campos, E. Talamoni Fonoff, C. Hamani, R. Lima Pagano (São Paulo, Brazil)

    Objective: To better understand the benefits of DBS in non-motor symptoms. Background: Parkinson's disease(PD) is a neurodegenerative disease characterized by the loss of dopaminergic neurons,…
  • 2017 International Congress

    NonMotor and Motor symptoms in Idiopathic Parkinson´s Disease and Secondary parkinsonism The “Parkinsons Well-Being MapTM” – a useful instrument in Clinical praxis.

    Ö. Skogar, M. Nilsson, S. Morberg (Jönköping SWEDEN, Sweden)

    Objective: To evaluate self-reported frequency and amplitude of the spectra of motor (MS) and Non Motor Symptoms (NMS) presented in the “Parkinsons Well-Being MapTM ”…
  • 2017 International Congress

    The effect and mechanism of acupuncture for pain in Parkinson’s disease

    S.-W. Yu, Y.-R. Wu, J.-J. Wang, C.-C. Tsai (Taoyuan, Taiwan)

    Objective: We aim to investigate the effect and mechanism of acupuncture in Parkinson’s disease (PD) patient with pain. Background: Acupuncture has been popularly practiced among…
  • 2017 International Congress

    Pain and Parkinson’s disease

    H. Wilson, T. Yousaf, G. Pagano, M. Politis (London, United Kingdom)

    Objective: We aimed to explore clinical correlates and risk factors in the development of pain, alongside the relationship between pain and striatal dopaminergic dysfunction in…
  • 2017 International Congress

    A double-blind, randomized, placebo controlled study of botulinum toxin type A for limb pain in advanced Parkinson’s disease

    V. Bruno, M. Freitas, D. Mancini, J. Liu, J. Miyasaki, S. Fox (CABA, Argentina)

    Objective: To evaluate safety, tolerability and efficacy of botulinum toxin type A for limb pain in advanced Parkinson´s disease (PD). Background: Pain is a frequent…
  • « Previous Page
  • 1
  • …
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • Next Page »
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley